Both predigested and undigested cranberry extracts modulated the microbiota composition in all donors, albeit with individual variations, with mucosal samples responding differently than luminal samples and predigested cranberry extract stimulating SCFA production.
Key Findings
Results
Both predigested and undigested cranberry extracts modulated gut microbiota composition in all six healthy adult donors tested in vitro.
Six healthy adult donors provided microbial communities for testing
Both undigested and predigested cranberry extract were tested alongside procyanidin A2 and hyperoside as controls
Modulation occurred in all donors despite inter-individual variations in magnitude and pattern
The type of extract (predigested vs. undigested) affected microbiota composition differently
Results
Mucosal microbial communities responded differently to cranberry polyphenols than luminal microbial communities.
Both luminal and mucosa-associated gut microbial communities were analyzed separately
The mucosal samples showed distinct compositional responses compared to luminal samples
This distinction highlights that site-specific microbial communities interact differently with polyphenolic substrates
The in vitro model allowed simultaneous assessment of both luminal and mucosal compartments
Results
Predigested cranberry extract stimulated short-chain fatty acid (SCFA) production, whereas undigested extract did not show the same effect.
SCFA production was specifically stimulated with predigested cranberry extract
SCFAs were among the microbial metabolites analyzed at different timepoints
This finding suggests that the digestive processing of cranberry polyphenols influences their ability to promote beneficial fermentation end-products
Undigested cranberry extract did not show equivalent SCFA stimulation
Results
Inter-individual differences in polyphenol metabolization patterns were observed, including production of 3,4-dihydroxyphenylpropionic acid (3,4-DHPPA), 3,4-DHPP-2-ol, and 3,4-dihydroxyphenyl acetic acid.
Metabolite levels and profile/composition were subject to extensive inter-individual variability across the six donors
Specific aromatic acid metabolites identified included 3,4-DHPPA, 3,4-DHPP-2-ol, and 3,4-dihydroxyphenyl acetic acid
Microbial metabolites analyzed included short-chain fatty acids, bile acids, and aromatic acids
Different timepoints were used to track metabolization patterns over time
Results
Semipolar compound analysis revealed broad metabolic variations in both cranberry-related metabolites and general microbial metabolites.
Cranberry-related metabolites identified included 4-vinylphenol and 3,4,5-trimethoxyphenylacetic acid
Microbial metabolites identified through semipolar compound analysis included indole-3-lactic acid
The analysis showed 'much broader metabolic variations' than previously characterized metabolites alone
This broader profiling approach captured both substrate-derived and microbiome-derived metabolic activity
Methods
The study used an in vitro model to test cranberry polyphenols on both luminal and mucosal microbial communities from six healthy adult donors at multiple timepoints.
Procyanidin A2 and hyperoside were included as polyphenol controls alongside cranberry extracts
Microbial community composition, polyphenolic substrate metabolization patterns, and multiple classes of microbial metabolites were all analyzed
Both undigested and predigested forms of cranberry extract were evaluated to model different states of oral/gastric processing
Bidirectional interactions between polyphenols and individual gut microbiota were assessed
What This Means
This research suggests that cranberry extracts can change the composition of gut bacteria communities, but the effects vary considerably from person to person and depend on both where in the gut the bacteria live (the free-floating luminal bacteria vs. the bacteria attached to the gut lining) and whether the cranberry has been pre-digested before reaching the gut. Scientists tested two forms of cranberry extract — one that mimicked what arrives in the colon after normal digestion and one that was unprocessed — on gut bacteria samples taken from six healthy adult volunteers, examining the bacteria in a laboratory dish system that models both the gut interior and the gut wall lining.
One of the more practically relevant findings is that the pre-digested cranberry extract boosted production of short-chain fatty acids, which are compounds produced by gut bacteria that are generally associated with gut health. The bacteria attached to the gut wall lining responded differently than the free-floating bacteria, suggesting that studying only one type may miss important effects. The researchers also found wide variation between individuals in how their gut bacteria broke down cranberry compounds into smaller molecules, with different people producing different amounts of metabolites like 3,4-dihydroxyphenylpropionic acid and related compounds.
This research suggests that the health effects of cranberry polyphenols may depend heavily on an individual's unique gut bacteria profile, since different people's microbiomes convert cranberry compounds into different metabolites in different amounts. The study also highlights that digestion itself transforms cranberry compounds before they reach gut bacteria, and this transformation matters for what effects occur. These findings add to the understanding of why some people may experience more health benefits from cranberry consumption than others, and point toward the importance of considering both the form of a food ingredient and individual microbiome differences when studying polyphenol health effects.
Schuren F, Baak M, Daniel N, Leijden B, Vanhoecke B, Meynier A, et al.. (2026). Cranberry Extract and Polyphenol Metabolites Modulate Luminal and Mucosal Microbiome.. International journal of molecular sciences. https://doi.org/10.3390/ijms27198722